Insider · CIK 0001791412

Nabulsi Azmi

Reports to the SEC for 1 company · FLORHAM PAK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001791412

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-27	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+79.2K sh	—	—	312,590
2025-02-27	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+55K sh	—	—	55,000
2025-01-21	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−7,886 sh	$6.59	−$52K	233,390
2024-12-19	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,118 sh	$8.00	−$8,944	239,303
2024-07-15	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−10.9K sh	$11.72	−$128K	240,421
2024-05-31	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+7,500 sh	—	—	249,567
2024-01-18	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+130K sh	—	—	130,000
2023-11-01	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+32.5K sh	—	—	242,067
2023-07-14	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+110K sh	—	—	209,567
2023-07-14	PHATPhathom Pharmaceuticals, Inc. · Stock OptionD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−70K sh	—	—	0
2023-07-14	PHATPhathom Pharmaceuticals, Inc. · Stock OptionD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−150K sh	—	—	0
2023-04-11	PHATPhathom Pharmaceuticals, Inc.P Purchase	Chief Operating Officer	PPurchase	+10K sh	$8.26	+$82.6K	99,567
2023-01-19	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+45K sh	—	—	89,567
2023-01-19	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+75K sh	—	—	75,000
2022-09-01	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+7,500 sh	—	—	41,971
2022-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+12K sh	—	—	33,378
2022-05-16	PHATPhathom Pharmaceuticals, Inc.P Purchase	Chief Operating Officer	PPurchase	+20K sh	$8.16	+$163K	785,700
2022-01-19	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Operating Officer	AAward	+19.5K sh	—	—	21,378
2022-01-19	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+97.5K sh	—	—	97,500
2021-05-04	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,968 sh	$36.15	−$71.2K	768,189
2021-05-04	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,400 sh	$37.09	−$51.9K	766,789
2021-05-04	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,089 sh	$37.86	−$41.2K	765,700
2021-05-03	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,290 sh	$37.85	−$162K	775,910
2021-05-03	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−5,753 sh	$38.59	−$222K	770,157
2021-04-05	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,252 sh	$35.66	−$152K	785,301
2021-04-05	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,316 sh	$36.37	−$157K	780,985
2021-04-05	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−785 sh	$37.11	−$29.1K	780,200
2021-04-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,405 sh	$37.28	−$127K	791,295
2021-04-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,742 sh	$38.14	−$66.4K	789,553
2021-03-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−600 sh	$44.59	−$26.8K	803,227
2021-03-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,833 sh	$46.16	−$223K	798,394
2021-03-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−24 sh	$46.73	−$1,121.52	798,370
2021-03-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,600 sh	$45.17	−$72.3K	796,770
2021-03-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,070 sh	$46.23	−$95.7K	794,700
2021-03-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,825 sh	$45.77	−$175K	805,375
2021-03-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,548 sh	$46.05	−$71.3K	803,827
2021-02-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,700 sh	$40.51	−$109K	815,584
2021-02-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−6,384 sh	$41.16	−$263K	809,200
2021-02-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−5,416 sh	$38.09	−$206K	818,284
2021-01-28	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+150K sh	—	—	150,000
2020-12-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,307 sh	$45.05	−$194K	841,195
2020-12-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,995 sh	$45.57	−$136K	838,200
2020-12-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−5,370 sh	$43.99	−$236K	847,330
2020-12-01	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,828 sh	$44.83	−$81.9K	845,502
2020-11-02	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−14.5K sh	$36.83	−$534K	852,700
2020-07-01	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+70K sh	—	—	70,000
2020-06-25	PHATPhathom Pharmaceuticals, Inc.G Gift	Chief Operating Officer	GGift	−867K sh	—	—	0
2020-06-25	PHATPhathom Pharmaceuticals, Inc.G Gift	Chief Operating Officer	GGift	+867K sh	—	—	867,200
2020-01-05	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−1,854 sh	$33.77	−$62.6K	823,700
2020-01-04	PHATPhathom Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,932 sh	$33.02	−$163K	833,268

Recent filings

Accepted (ET)
Mar 34
Nabulsi Azmi0000950170-25-031034
SEC(opens sec.gov)
Jan 234
Nabulsi Azmi0000950170-25-008353
SEC(opens sec.gov)
Dec 204
Nabulsi Azmi0000950170-24-139063
SEC(opens sec.gov)
Jul 174
Nabulsi Azmi0000950170-24-084186
SEC(opens sec.gov)
May 314
Nabulsi Azmi0000950170-24-067539
SEC(opens sec.gov)
Jan 224
Nabulsi Azmi0001209191-24-002020
SEC(opens sec.gov)
Nov 34
Nabulsi Azmi0001209191-23-054352
SEC(opens sec.gov)
Jul 174
Nabulsi Azmi0001209191-23-042453
SEC(opens sec.gov)
Apr 114
Nabulsi Azmi0001209191-23-023989
SEC(opens sec.gov)
Jan 204
Nabulsi Azmi0001209191-23-004339
SEC(opens sec.gov)
Sep 24
Nabulsi Azmi0001209191-22-048471
SEC(opens sec.gov)
May 204
Nabulsi Azmi0001209191-22-031090
SEC(opens sec.gov)
May 164
Nabulsi Azmi0001209191-22-029453
SEC(opens sec.gov)
Jan 214
Nabulsi Azmi0001209191-22-004496
SEC(opens sec.gov)
May 44
Nabulsi Azmi0001209191-21-030141
SEC(opens sec.gov)

Companies

Phathom Pharmaceuticals, Inc.Chief Operating OfficerPHAT

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PAK, NJ, 07932